Warner Douglas J has filed 5 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 25000 shares of Tyra Biosciences, Inc. ($TYRA) on May 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | Tyra Biosciences, Inc. | $TYRA | Warner Douglas J | Chief Medical Officer | A | Common Stock | 25000 | $0.00 | 25,000.0000 | 59,670,757 | 9999.99% | 0.04% |
| May 5, 2026 | Tyra Biosciences, Inc. | $TYRA | Warner Douglas J | Chief Medical Officer | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 59,670,757 | 9999.99% | 0.14% |
| Aug. 7, 2025 | Tyra Biosciences, Inc. | $TYRA | Warner Douglas J | Chief Medical Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 57,217,746 | 9999.99% | 0.35% |
| Sept. 9, 2024 | Tyra Biosciences, Inc. | $TYRA | Warner Douglas J | Chief Medical Officer | A | Stock Option (Right to Buy) | 260000 | $0.00 | 260,000.0000 | 42,704,876 | 9999.99% | 0.61% |
| Feb. 19, 2024 | eFFECTOR Therapeutics, Inc. | $EFTR | Warner Douglas J | Chief Medical Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |